Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and

Xiaodong Li1, Xuedong Yin1, Heyi Bao2

  • 1Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.

Abstract

Insights

This study shows circular RNA ITCH (circITCH) is downregulated in hepatocellular carcinoma (HCC) and enhances sorafenib sensitivity by regulating the miR-20b-5p/PTEN/PI3K/Akt pathway, offering a potential therapeutic target for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Sorafenib resistance is a major challenge in advanced hepatocellular carcinoma (HCC) treatment, leading to poor patient outcomes.
  • Understanding the molecular mechanisms underlying sorafenib resistance is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of circular RNA ITCH (circITCH) in regulating sorafenib resistance in HCC.
  • To elucidate the underlying molecular mechanisms by which circITCH affects sorafenib sensitivity.

Main Methods:

  • Quantitative real-time PCR to assess circITCH expression in HCC tissues and cell lines.
  • Cell transfection, MTT assays, flow cytometry, and Transwell assays to evaluate cell viability, apoptosis, and migration.
  • Bioinformatic analysis, dual luciferase reporter assays, and Western blot to identify and validate downstream targets of circITCH.

Main Results:

  • circITCH expression was significantly downregulated in HCC tissues and cells, particularly in sorafenib-resistant cells.
  • Overexpression of circITCH in resistant HCC cells enhanced sorafenib sensitivity, promoted apoptosis, and reduced migration.
  • circITCH was found to elevate PTEN expression by negatively regulating miR-20b-5p, thereby inactivating the PI3K/Akt signaling pathway.

Conclusions:

  • circITCH enhances sorafenib sensitivity in HCC by modulating the miR-20b-5p/PTEN/PI3K/Akt signaling cascade.
  • circITCH represents a promising therapeutic target for overcoming sorafenib resistance in hepatocellular carcinoma.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K